Aerie Pharmaceuticals Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$138.4M
Industry:Pharma
Founded:2005
Lead Investor(s):Cantor Fitzgerald & Co
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Aerie Pharmaceuticals's estimated revenue is currently $24.2M per year.
  • Aerie Pharmaceuticals received $86.2M in venture funding in January 2018.
  • Aerie Pharmaceuticals's estimated revenue per employee is $59413
  • Aerie Pharmaceuticals's total funding is $138.4M.

Employee Data

  • Aerie Pharmaceuticals has 407 Employees.
  • Aerie Pharmaceuticals grew their employee count by 3% last year.
  • Aerie Pharmaceuticals currently has 6 job openings.

Executive Contacts

NameTitle
Casey KopczynskiChief Scientific Officer
Richard RubinoChief Financial Officer
Scott CassadyDirector of Sales - Central Region
Evan HockmanMarketing Director
Puiwah BraswellDirector, Clinical Operations
Christopher StatenVice President of Finance
Minh LuDirector, Supply Chain
Maria ZanardoRegional Sales Director
Ted WheelerDirector of Quality Assurance
Hayley McKeeSenior Director Clinical Research

What Is Aerie Pharmaceuticals?

Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialisation of first-in-class therapies for the treatment of glaucoma and other diseases of the eye. See the future of eye care with Aerie.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

407

Number of Employees

$24.2M

Revenue (est)

6

Current Jobs

3%

Employee Growth %

$138.4M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
TARGET PharmaSo...
$14.3M7623%$637.8K
Quality Chemica...
$31.4M1678%
LMK Clinical Re...
$7M376%
PMG Research
$39.2M209-1%
3D Communicatio...
$12.1M642%
WEP Clinical
$9.8M5230%
Tanner Pharma G...
$9.8M5213%
Flow Sciences
$8.2M44-2%
VeraSci
$22.7M12117%
Ribometrix
$6.4M3455%

Aerie Pharmaceuticals News

09/03/2019 - Aerie Pharmaceuticals to Offer $250 Million Convertible Senior Notes Due 2024

Aerie Pharmaceuticals, Inc. (AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of ...

09/08/2019 - Durham-based Aerie Pharmaceuticals looks to raise $275M

DURHAM — Aerie Pharmaceuticals, a developer of therapies for eye diseases, has launched an offering of $250 million of convertible senior ...

09/03/2019 - Aerie Pharma prices upsized convertible debt offering

Aerie Pharmaceuticals (NASDAQ:AERI) is offering $275M (from $250M) of 1.50% convertible senior notes due 2024. Initial buyers have the ...

Aerie Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2005-10-13$21.0MAAlta Partners, Texas Pacific Group VenturesArticle
2011-03-08$30.0MBClarus Ventures, Sofinnova VenturesArticle
2013-10-28$67.0MUndisclosedRBC Capital MarketsArticle
2014-09-10$125.0MUndisclosedDeerfield Management CompanyArticle
2016-09-19$125.0MUndisclosedCantor Fitzgerald & CoArticle
2017-05-26$50.0MUndisclosedCantor Fitzgerald & Co.Article
2018-01-25$86.2MUndisclosedCantor Fitzgerald & CoArticle

Aerie Pharmaceuticals Executive Hires

DateNameTitleReference
2012-10-19Richard J. RubinoCFOArticle
2013-04-05Vicente AnidoChairmanArticle
2013-08-06Thomas MitroPresident/COOArticle
2014-02-25Marvin J. GarrettVP Regulatory Affairs/Quality AssuranceArticle
2014-06-17Craig R. SkenesVP Business DevelopmentArticle
2014-07-08Michael McCleereyVP MarketingArticle
2016-12-20Judith RobertsonChief Commercial OfficerArticle
2017-01-24Kristine EricksonVP Clinical ResearchArticle
2017-02-06Barry IvinDirector of New Manufacturing Plant in IrelandArticle
2017-02-07Huan ShengDir Clinical Research And Drug SafetyArticle
2017-04-11Gary MenichiniVP SalesArticle
2017-04-25Raymond WysmierskiDir ComplianceArticle
2017-05-17Jessica CrespoDir AccountingArticle
2017-07-26Richard HalprinDirector of Professional AffairsArticle
2017-08-15Isabel MoredoEastern Regional Dir Medical Science LiaisonsArticle
2017-08-29Deanne MelloyVP MarketingArticle
2017-09-20Tori ArensVP Drug Product ManufacturingArticle
2017-09-26Sheila ElliottWestern Regional Director of Medical Science LiaisonsArticle
2017-10-02David BiddellRegional Sales Director Southeast RegionArticle
2017-10-03Ann KeevansDir Human Resources EuropeArticle
2017-10-31John MaltmanVP Medical AffairsArticle
2017-11-28Nhi OngDIR AnalyticsArticle
2017-12-04Paul Baevp Human ResourcesArticle
2017-12-05Heather JohnsonReg Sales Dir Northeast RegionArticle
2018-01-03Julia WilliamsDir Medical AffairsArticle
2018-01-17Nils HauptmannDir Regulatory Affairs and PharmacovigilanceArticle
2018-02-02Tad HeitmannHead of CommunicationsArticle
2018-02-09Brad FullerDirector of National AccountsArticle
2018-02-13Scott CassadyRegional Sales DirectorArticle
2018-02-21John LaRoccaGeneral CounselArticle
2018-04-13Scott LaranjoDirector, Marketing, Roclatan?Article
2018-05-02Concetta PerroCommercial CounselArticle
2018-05-31Lynda NguyenDir Project ManagementArticle
2018-06-19William CoppolaIntellectual Property CounselArticle
2018-07-17Randall BrownDir Payer MarketingArticle
2018-08-21Jeffrey WhiteDir Toxicology & PharmacokineticsArticle
2018-09-11Thomas ShepardVP, Implant ManufacturingArticle
2018-09-12Robert FinanDir FinanceArticle
2018-09-25Damien MonaghanQuality DirectorArticle
2019-01-03Ami BavishiDirector, Investor RelationsArticle
2019-03-26David EllisDirector, Chemistry,Article

Aerie Pharmaceuticals Hiring Plans

DateNumber of EmployeesLocationReference
2017-01-1650AthloneArticle
2017-10-1011Article